Caterina Riillo

1.4k total citations
25 papers, 536 citations indexed

About

Caterina Riillo is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Caterina Riillo has authored 25 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Caterina Riillo's work include CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (4 papers). Caterina Riillo is often cited by papers focused on CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (4 papers). Caterina Riillo collaborates with scholars based in Italy, United States and Netherlands. Caterina Riillo's co-authors include Pierfrancesco Tassone, Maria Teresa Di Martino, Francesca Scionti, Katia Grillone, Daniele Caracciolo, Pierosandro Tagliaferri, Stefano Alcaro, Roberta Rocca, Mariamena Arbitrio and Pierosandro Tagliaferri and has published in prestigious journals such as Nature reviews. Cancer, Blood and International Journal of Molecular Sciences.

In The Last Decade

Caterina Riillo

24 papers receiving 534 citations

Peers

Caterina Riillo

ONCOL

HEMAT

IMMUN

Xibao Yu China

Justin Cidado United States

Abdulraheem Alshareef Canada

Andrea Ghelli Luserna di Rorà Italy

Maria Unni Rømer Denmark

Anna Wojtuszkiewicz Netherlands

Nidhi Jyotsana Germany

Sylvanie Surget France

Diede Brunen Netherlands

Xibao Yu China

Caterina Riillo

384 ×1.0

265 ×1.3

155 ×1.2

ONCOL

67 ×1.0

HEMAT

130 ×2.2

IMMUN

Citations per year, relative to Caterina Riillo Caterina Riillo (= 1×) peers Xibao Yu

Countries citing papers authored by Caterina Riillo

Since Specialization

Citations

This map shows the geographic impact of Caterina Riillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Riillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Riillo more than expected).

Fields of papers citing papers by Caterina Riillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caterina Riillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Riillo. The network helps show where Caterina Riillo may publish in the future.

Co-authorship network of co-authors of Caterina Riillo

This figure shows the co-authorship network connecting the top 25 collaborators of Caterina Riillo. A scholar is included among the top collaborators of Caterina Riillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caterina Riillo. Caterina Riillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beringer, Dennis X., Trudy Straetemans, Susana Minguet, et al.. (2025). Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy. Nature reviews. Cancer. 25(8). 590–612. 4 indexed citations

Riillo, Caterina, Sabine Heijhuurs, Jiali Zheng, et al.. (2025). Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control. Cellular and Molecular Immunology. 23(1). 79–93.

Grillone, Katia, Paolo Cremaschi, Jussara Amato, et al.. (2024). An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma. Blood. 144(16). 1705–1721. 10 indexed citations

Staropoli, Nicoletta, Domenico Ciliberto, Francesco Luciano, et al.. (2023). The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 193. 104229–104229. 4 indexed citations

Caracciolo, Daniele, Nicoletta Polerà, Beatrice Belmonte, et al.. (2023). UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma. British Journal of Haematology. 204(2). 555–560. 1 indexed citations

Polerà, Nicoletta, Antonia Mancuso, Caterina Riillo, et al.. (2023). The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas. Cancers. 15(6). 1647–1647. 1 indexed citations

Scionti, Francesca, Giada Juli, Roberta Rocca, et al.. (2023). TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma. Journal of Experimental & Clinical Cancer Research. 42(1). 71–71. 14 indexed citations

Caracciolo, Daniele, Antonia Mancuso, Nicoletta Polerà, et al.. (2023). The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives. Experimental Hematology and Oncology. 12(1). 5–5. 15 indexed citations

Worel, Nina, Per Ljungman, Nina Knelange, et al.. (2023). Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP). Bone Marrow Transplantation. 58(12). 1348–1356. 4 indexed citations

10.

Ciliberto, Domenico, Nicoletta Staropoli, Cristina Napoli, et al.. (2023). First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis. Heliyon. 9(8). e18696–e18696. 4 indexed citations

11.

Staropoli, Nicoletta, Caterina Riillo, Domenico Ciliberto, et al.. (2023). Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity. Frontiers in Oncology. 13. 1145986–1145986. 4 indexed citations

12.

Riillo, Caterina, Nicoletta Polerà, Maria Teresa Di Martino, et al.. (2023). A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer. Journal of Translational Medicine. 21(1). 301–301. 2 indexed citations

13.

Grillone, Katia, Caterina Riillo, Roberta Rocca, et al.. (2022). The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma. International Journal of Molecular Sciences. 23(18). 10222–10222. 32 indexed citations

14.

Siciliano, Maria Anna, Domenico Ciliberto, Maria D’Apolito, et al.. (2022). Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis. ESMO Open. 7(3). 100465–100465. 25 indexed citations

15.

Caracciolo, Daniele, Giada Juli, Caterina Riillo, et al.. (2022). Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin. Journal of Translational Medicine. 20(1). 482–482. 4 indexed citations

16.

Tirinato, Luca, Francesca Scionti, Maria Laura Coluccio, et al.. (2020). Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling. ACS Omega. 5(47). 30436–30443. 29 indexed citations

17.

Grillone, Katia, Caterina Riillo, Francesca Scionti, et al.. (2020). Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”. Journal of Experimental & Clinical Cancer Research. 39(1). 117–117. 166 indexed citations

18.

Caracciolo, Daniele, Francesca Scionti, Giada Juli, et al.. (2020). Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma. Haematologica. 106(1). 185–195. 34 indexed citations

19.

Cantafio, Maria Eugenia Gallo, Maria Anna Siciliano, Caterina Riillo, et al.. (2019). Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. Journal of Hematology & Oncology. 12(1). 32–32. 33 indexed citations

20.

Botta, Cirino, Giuseppe Gaipa, Maria Eugenia Gallo Cantafio, et al.. (2018). Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood. 132(Supplement 1). 1418–1418. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact